KernanWNOvbiageleBBlackHR. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45
(7):2160–2236.
2.
ParaskevasKIMikhailidisDPVeithFJ. Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomes. J Vasc Surg. 2010;52
(5):1367–1375.
3.
SimonsJPGoodneyPPBarilDT. The effect of postoperative stroke and myocardial infarction on long-term survival after carotid revascularization. J Vasc Surg. 2013;57
(6):1581–1588.
4.
PiňeroPGonzálezAMartínezE. Volume and composition of emboli in neuroprotected stenting of the carotid artery. AJNR Am J Neuroradiol. 2009;30
(3):473–478.
5.
MarderVJChuteDJStarkmanS. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke. 2006;37
(8):2086–2093.
6.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333
(24):1581–1587.
7.
KhatriPAbruzzoTYeattsSD. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73
(13):1066–1072.
8.
LeesKRBluhmkiEvon KummerR. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375
(9727):1695–1703.
9.
The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28
(11):2109–2118.
10.
DiedlerJAhmedNSykoraM. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke. 2010;41(2):288–294.
11.
BravoYMarti-FabregasJCochoD. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis. Cerebrovasc Dis. 2008;26
(2):126–133.
12.
BourcierTLibbyP. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20
(2):556–562.
CollinsRArmitageJParishSSleightPPetoR; Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363
(9411):757–767.
15.
AmarencoPBogousslavskyJCallahanAIII. High-dose Atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355
(6):549–559.
16.
VergouwenMDde HaanRJVermeulenMRoosYB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke. 2008;39
(2):497–502.
17.
AmarencoPLabreucheJLavalleePTouboulPJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke. 2004;35
(12):2902–2909.
18.
HackamDGWoodwardMNewbyLK. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation. 2011;124
(20):2233–2242.
19.
MeierNNedeltchevKBrekenfeldC. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 2009;40
(5):1729–1737.
20.
CappellariMDelucaCTinazziM. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. J Neurol Sci. 2011;308
(1-2):128–134.
21.
Martinez-RamirezSDelgado-MederosRMarinR. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol. 2012;259
(1):111–118.
22.
UyttenboogaartMKochMWKoopmanKVroomenPCLuijckxGJDe KeyserJ. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J Neurol. 2008;255
(6):875–880.
23.
CordenierADe SmedtABrounsR. Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies. Acta Neurol Belg. 2011;111
(4):261–267.
24.
EngelterSTSoinneLRinglebP. IV thrombolysis and statins. Neurology. 2011;77
(9):888–895.
25.
ScheitzJFNolteCHEndresM. Should statins be paused or discontinued after thrombolysis or acute intracerebral hemorrhage? No!Stroke. 2013;44
(5):1472–1476.
26.
LiapisCDBellPFMikhailidisDP. ESVS Guidelines: section A—prevention in patients with carotid stenosis. Curr Vasc Pharmacol. 2010;8
(5):673–681.
27.
AkinFAycaBKoseN. Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia. Angiology. 2013;64
(8):621–625.
28.
HikitaHKurodaSOosakaY. Impact of statin use before the onset of acute myocardial infarction on coronary plaque morphology of the culprit lesion. Angiology. 2013;64
(5):375–378.
29.
ParaskevasKINicolaidesANMikhailidisDP. Statins and venous thromboembolism: the jury is still out. Angiology. 2013;64
(7):489–491.
30.
MinderCMBlumenthalRSBlahaMJ. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks. Curr Opin Cardiol. 2013;28
(5):554–560.
TziomalosKAthyrosVGMikhailidisDP. Statin discontinuation: an underestimated risk?Curr Med Res Opin. 2008;24
(11):3059–3062.
33.
ParaskevasKIKoupidisSGentimiFTzovarasAA. Statin discontinuation: counterbalancing the benefits with the potential risks. Arch Med Sci. 2011;7
(6):1076–1077.
34.
FallouhNChopraV. Statin withdrawal after major noncardiac surgery: risks, consequences and preventive strategies. J Hosp Med. 2012;7
(7):573–579.
35.
KhanMQureshiAI. Factors associated with increased rates of post-procedural stroke or death following carotid artery stent placement: a systematic review. J Vasc Interv Neurol. 2014;7
(1):11–20.
36.
PadmaSMajazM. Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset. Arch Med Sci. 2010;6(3):303–315.
